ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Berlin, BE, DEU:

2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy (PREDICT)

Second-line therapy with Nal-IRI after failure gemcitabine/nab-paclitaxel in advanced pancreatic cancer - predictive role of 1st-li...

Active, not recruiting
Locally Advanced Pancreatic Cancer
Metastatic Pancreatic Cancer
Drug: Irinotecan Liposomal Injection [Onivyde]

Phase 3

AIO-Studien

Bad Saarow, Germany and 34 other locations

patients with hepatic oligometastatic adenocarcinoma of the pancreas will receive neoadjuvant combination chemotherapy (liposomal irinotecan...

Enrolling
Pancreatic Cancer
Metastasis
Drug: nal-irinotecan (nal-iri) (Onyvide), oxaliplatin (ox), 5-fluouracil (5-FU), folinic acid (FA)

Phase 2

University of Cologne

Berlin, Germany and 10 other locations

or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2, Phase 3

Panbela Therapeutics

Berlin, Germany and 91 other locations

A Phase Ib/II, open-label, multicenter, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor...

Active, not recruiting
Pancreatic Adenocarcinoma
Drug: Gemcitabine
Drug: Bevacizumab

Phase 1, Phase 2

Roche
Roche

Berlin, Germany and 26 other locations

to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...

Enrolling
Non-small Cell Lung Cancer
Colorectal Neoplasms
Drug: PF-08046049

Phase 1

Seagen
Seagen

Berlin, Other, Germany and 21 other locations

This is an open-label, multicenter, global Phase 2 basket study of entrectinib (RXDX-101) for the treatment of patients with solid tumors th...

Active, not recruiting
Breast Cancer
Neuroendocrine Tumors
Drug: Entrectinib

Phase 2

Roche
Roche

Berlin, Germany and 122 other locations

efficacy of AZD9574 individually and in combination with anti-cancer agents in 490 participants with advanced cancer that has recur...

Enrolling
Advanced Solid Malignancies
Drug: AZD9574
Drug: Temozolomide

Phase 1, Phase 2

AstraZeneca
AstraZeneca

Berlin, Germany and 30 other locations

liposome injection in combination with other approved drugs used for cancer therapy, namely 5 fluorouracil/leucovorin (5FU/LV) plus oxalipla ...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Berlin, Germany and 199 other locations

Locations recently updated

activity of LY3962673 as monotherapy and in combination with other chemotherapy agents in participants with KRAS G12D-mutant advanced solid tumor...

Enrolling
Non-small Cell Lung Cancer
Pancreatic Ductal Adenocarcinoma
Drug: nab-paclitaxel
Drug: Oxaliplatin

Phase 1

Lilly
Lilly

Berlin, Germany and 42 other locations

in participants with advanced pheochromocytoma/paraganglioma (PPGL), pancreatic neuroendocrine tumor (pNET), von Hippel-Lindau (VHL...

Enrolling
Advanced Gastrointestinal Stromal Tumor
HIF-2α Mutated Cancers
Drug: Belzutifan

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Berlin, Germany and 70 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems